Imbio PHA (4.0.0) vs Rhythm360
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your primary need is rapid, AI-driven quantitative analysis of cardiac structures from CT pulmonary angiogram (CTPA) scans. This tool is ideal for radiologists and cardiologists seeking to automatically measure right and left ventricle diameters, main pulmonary artery, and aorta diameters to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. It excels in providing quick, objective imaging insights for acute diagnostic scenarios.
View Imbio PHA (4.0.0) →Choose Rhythm360 if…
Choose Rhythm360 if your cardiology practice requires a comprehensive, AI-powered platform to unify and manage cardiac monitoring data from a diverse range of devices for chronic patient care. This solution is best suited for reducing alert fatigue, providing actionable insights for hypertension, heart failure, and rhythm management, and streamlining operational workflows through bi-directional EHR integration and automated CPT code documentation. It is designed for efficient, long-term remote patient monitoring and management across multiple vendors.
View Rhythm360 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | Rhythm360 |
|---|---|---|
| Pricing | Unknown | Flexible pricing model that scales with clinic size and platform usage. |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud-based SaaS platform |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rhythm360Rhythm360 offers a comprehensive web and mobile application, extensive bi-directional EHR integration, and AI-driven alert triage designed to reduce clinician burden and streamline workflows across various cardiac monitoring devices. Imbio PHA, while integrating well into existing radiology DICOM workflows, provides a more specialized usability experience focused on image analysis rather than broad clinical workflow management.
Clinical Value
Rhythm360While Imbio PHA provides FDA-cleared, quantitative diagnostic and risk stratification data from CTPA scans for acute conditions like pulmonary embolism and hypertension, Rhythm360 offers continuous, actionable insights for chronic conditions such as hypertension, heart failure, and rhythm management. Rhythm360's AI-driven alert triage, predictive algorithms for GDMT optimization, and 80% faster response times for critical alerts suggest a broader and more sustained impact on patient outcomes through proactive management.
Pricing & Value
Rhythm360Rhythm360 provides a flexible, SaaS-based pricing model that scales with clinic size and usage, and explicitly highlights significant financial value through automated CPT code documentation and billing, with reported increases in billed units and revenue. Imbio PHA's pricing information is only available upon contact, offering no transparency or explicit value-added financial benefits in its description.
Enterprise Readiness
Rhythm360Both tools demonstrate strong enterprise readiness with HIPAA compliance and BAA. Imbio PHA offers flexible deployment including on-premise options. However, Rhythm360's extensive list of bi-directional EHR integrations with major systems (Epic, Cerner, Athenahealth, etc.) and its vendor-neutral data aggregation across all major cardiac device OEMs provide superior interoperability and scalability for complex enterprise environments.
Innovation
Rhythm360Rhythm360 showcases broader innovation by applying AI across multiple facets of cardiac care, including vendor-neutral data aggregation, advanced AI Data Normalization (e.g., PDF parsing via computer vision), predictive algorithms for heart failure management, and intelligent alert triage. Imbio PHA's innovation is focused on automating a specific, high-value medical image processing task.
Support & Docs
Rhythm360Rhythm360 offers robust support, including optional 24/7/365 oversight by certified cardiac technicians, a comprehensive online knowledge base, and direct phone/email support. Imbio PHA provides user manuals and a support email for technical issues, but lacks the explicit, proactive clinical oversight and extensive documentation resources offered by Rhythm360.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | Rhythm360 |
|---|---|---|
| Name | Imbio PHA (4.0.0) | Rhythm360 |
| Company | Imbio | RhythmScience |
| Description | FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue. |
| Primary Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Key Features (Examples) | Automated measurement of right and left ventricle diameters, Calculates RV/LV and PA/Ao ratios, Generates annotated DICOM images | Vendor-neutral data aggregation, AI-driven alert triage, Bi-directional EHR integration |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Rhythm360.